Effects of 5-HT2C receptor (5-HT2CR) ligands on receptor internalization and desensitization

被引：0
|
作者：
Schlag, BD [1 ]
Lou, ZW [1 ]
Fennell, M [1 ]
Dunlop, J [1 ]
机构：
[1] Wyeth Ayerst Res, Neurosci Discovery Res, Princeton, NJ 08543 USA
来源：
FASEB JOURNAL | 2003年 / 17卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1022 / A1022
页数：1
相关论文
共 50 条
  • [21] NOVEL SEROTONIN (5-HT) 2C RECEPTOR (5-HT2CR) TRANSGENIC MODEL: PHENOTYPIC EXPLORATIONS
    Anastasio, N. C.
    Stutz, S. J.
    Morabito, M. V.
    Hernandez, C. M.
    Dineley, K. T.
    Emeson, R. B.
    Cunningham, K. A.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (06) : 321A - 321A
  • [22] The 5-HT2C receptor, a target for panaceas
    Kennett, GA
    Bickerdike, MJ
    Vickers, SP
    Lightowler, SL
    Dourish, CT
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 : U47 - U47
  • [23] Design, Synthesis, In Vitro, and In Silico Evaluation of a Novel Series of Serotonin 5-HT2C Receptor (5-HT2CR) Positive Allosteric Modulators (PAMs)
    Wold, Eric A.
    Wild, Christopher T.
    Chen, Jianping
    Pazdrak, Konrad
    Garcia, Erik J.
    Anastasio, Noelle C.
    White, Mark A.
    Chen, Haiying
    Cunningham, Kathryn A.
    Zhou, Jia
    FASEB JOURNAL, 2019, 33
  • [24] New 5-HT2c receptor agonists
    Bishop, MJ
    Nilsson, BM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (11) : 1691 - 1705
  • [25] Imaging the 5-HT2C receptor with PET: Evaluation of 5-HT2C and 5-HT2A affinity of pimavanserin in the primate brain
    Ridler, Khanum
    Rizzo, Gaia
    Burstein, Ethan S.
    Forsberg Moren, Anton
    Stepanov, Vladimir
    Halldin, Christer
    Rabiner, Eugenii A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2025, 45 (02): : 352 - 364
  • [26] 5-HT2C receptor ligands in the treatment of obesity and type 2 diabetes
    Heisler, L. K.
    Lam, D. D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S182 - S182
  • [27] Synthesis and Biological Evaluation of Isoxazoline and Isoxazole Derivatives as 5-HT2A and 5-HT2C Receptor Ligands
    Youn, Hae Suk
    Lee, Eun Ju
    Lee, Jie Eun
    Park, Woo-Kyu
    Baek, Du-Jong
    Cho, Yong Seo
    Koh, Hun Yeong
    Choo, Hyunah
    Pae, Ae Nim
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2009, 30 (08): : 1873 - 1876
  • [28] Novel pyrimidoazepine analogs as serotonin 5-HT2A and 5-HT2C receptor ligands for the treatment of obesity
    Yang, Ha Yun
    Tae, Jinsung
    Seo, Yong Wan
    Kim, Yoon Jung
    Im, Hye Yeon
    Choi, Gil Don
    Cho, Heeyeong
    Park, Woo-Kyu
    Kwon, Oh Seung
    Cho, Yong Seo
    Ko, Minkyung
    Jang, HyunSeo
    Lee, Jaeick
    Choi, Kihang
    Kim, Chan-Hwa
    Lee, Jiyoun
    Pae, Ae Nim
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 63 : 558 - 569
  • [29] DESENSITIZATION OF THE TRANSFECTED HUMAN 5-HT2C RECEPTOR IS ACCOMPANIED BY A DECREASED AFFINITY OF THE RECEPTOR FOR [H-3] 5-HT
    BRIDDON, SJ
    LESLIE, RA
    ELLIOTT, JM
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 : P218 - P218
  • [30] Ligand-directed serotonin 5-HT2C receptor desensitization and sensitization
    Felsing, Daniel E.
    Canal, Clinton E.
    Booth, Raymond G.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 848 : 131 - 139
12345